Detected ·
Ray Therapeutics
——
Ray Therapeutics, a Berkeley-based biotech developing optogenetic gene therapies to restore vision, closed an upsized and oversubscribed $125M Series B led by Janus Henderson Investors.
- Website
- —
- —
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-23 20:03:57 UTC
- Signal ID
- eb153ef4-6832-4d14-94cd-499c62c0f3c9
As the API returns it
{
"id": "eb153ef4-6832-4d14-94cd-499c62c0f3c9",
"created_at": "2026-04-23T20:03:57.689909Z",
"company_name": "Ray Therapeutics",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Ray Therapeutics, a Berkeley-based biotech developing optogenetic gene therapies to restore vision, closed an upsized and oversubscribed $125M Series B led by Janus Henderson Investors.*"
}